Overview

At CD ComputaBio, we combine advanced computational capabilities with a rich understanding of the life sciences to provide the most comprehensive and specialized drug-like property calculation services. Our services are ideal for drug discovery research and development programs, as they provide key insights into the physicochemical properties of potential drug compounds, allowing them to be rapidly moved to clinical trials and beyond.

Our Services

At CD ComputaBio, we understand the enormous challenges of identifying and developing promising drug candidates. Our drug-like property computational services are designed to assist pharmaceutical companies, research organizations, and biotechnology companies in evaluating the drug-like properties of their compounds. We utilize advanced computational algorithms and expertise to provide the following services:

• Predictive Modeling

Our team utilizes state-of-the-art machine learning and Quantitative Structure-Activity Relationship (QSAR) models to predict a wide range of drug-like properties, including pharmacokinetic parameters, bioavailability, metabolic stability, solubility, and more.

• Molecular Descriptor Analysis

We use a variety of molecular descriptors to comprehensively characterize the physicochemical and structural properties of compounds to assess their suitability for further development as therapeutics.

• Virtual Screening

Through virtual screening strategies, we identify compounds with the best drug-like properties from large chemical libraries and help clients prioritize lead candidates for further experimental validation.

• Drug Optimization

By analyzing calculated drug-like properties, we provide insights into the optimization of compounds to increase their potential for successful clinical development.

Applications

The computation of drug-like properties plays a crucial role in many stages of the drug discovery and development process:

• From Hit to Lead Optimization: Identifying lead compounds with good drug-like properties early in the discovery phase accelerates the entry of promising drug candidates into lead optimization and preclinical studies.
• Candidate Screening: Drug-like property assessment helps rationalize the selection of lead candidates for further development, thereby reducing the risk of late-stage clinical trial failure.
• Chemical Library Prioritization: Virtual screening based on calculated drug-like properties efficiently prioritizes compounds in the chemical library, enabling researchers to focus on molecules with the highest likelihood of success.

Sample Requirements

Deliverables

Why Choose Us?

• Pharmacophore Screening
• Pharmacokinetic Simulation
• Drug solubility and permeability prediction
• Prediction of Drug-Like Properties

Name *

Phone

Email *

Products/Services Interested *

Project Description

Submit